BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14734126)

  • 1. Haptoglobin phenotype correlates with development of cardiac transplant vasculopathy.
    Densem CG; Wassel J; Cooper A; Yonan N; Brooks NH; Keevil B
    J Heart Lung Transplant; 2004 Jan; 23(1):43-9. PubMed ID: 14734126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation.
    Densem CG; Hutchinson IV; Cooper A; Yonan N; Brooks NH
    J Heart Lung Transplant; 2000 Jun; 19(6):551-6. PubMed ID: 10867335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    Transpl Immunol; 2004 Nov; 13(3):211-7. PubMed ID: 15381204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
    J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    J Heart Lung Transplant; 2001 Dec; 20(12):1265-73. PubMed ID: 11744409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
    Raichlin ER; McConnell JP; Lerman A; Kremers WK; Edwards BS; Kushwaha SS; Clavell AL; Rodeheffer RJ; Frantz RP
    J Heart Lung Transplant; 2007 Aug; 26(8):826-33. PubMed ID: 17692787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac allograft vasculopathy: the green lane hospital experience 1987-1998.
    Dixon SR; Ruygrok PN; Agnew TM; Lund M; Aldersley PF; Gibbs HC; Whitlock RM; Haydock DA; Coverdale HA
    N Z Med J; 1999 Nov; 112(1099):417-20. PubMed ID: 10678223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.
    Haji SA; Starling RC; Avery RK; Mawhorter S; Tuzcu EM; Schoenhagen P; Cook DJ; Ratliff NB; McCarthy PM; Young JB; Yamani MH
    J Heart Lung Transplant; 2004 Mar; 23(3):277-83. PubMed ID: 15019636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
    Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
    Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography.
    Derumeaux G; Redonnet M; Soyer R; Cribier A; Letac B
    J Heart Lung Transplant; 1998 Mar; 17(3):259-67. PubMed ID: 9563602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation.
    Aziz T; Hasleton P; Hann AW; Yonan N; Deiraniya A; Hutchinson IV
    J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):700-8. PubMed ID: 10733758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experience.
    Aranda JM; Pauly DF; Kerensky RA; Cleeton TS; Walker TC; Schofield RS; Leach D; Lin L; Monroe V; Calderon RE; Hill JA
    J Heart Lung Transplant; 2002 Aug; 21(8):860-6. PubMed ID: 12163085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of IFN-gamma polymorphism on the development of coronary vasculopathy after cardiac transplantation.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    Ann Thorac Surg; 2004 Mar; 77(3):875-80. PubMed ID: 14992891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation.
    Roguin A; Ribichini F; Ferrero V; Matullo G; Herer P; Wijns W; Levy AP
    Am J Cardiol; 2002 Apr; 89(7):806-10. PubMed ID: 11909563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation.
    Ciliberto GR; Ruffini L; Mangiavacchi M; Parolini M; Sara R; Massa D; De Maria R; Gronda E; Vitali E; Parodi O
    Eur Heart J; 2001 Jun; 22(11):964-71. PubMed ID: 11428820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients.
    Dupont L; Eide IA; Hartmann A; Christensen JH; Åsberg A; Jenssen T; Krarup H; Svensson M
    Prog Transplant; 2017 Dec; 27(4):386-391. PubMed ID: 29187131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
    Costacou T; Ferrell RE; Orchard TJ
    Diabetes; 2008 Jun; 57(6):1702-6. PubMed ID: 18332093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haptoglobin phenotype and coronary artery collaterals in diabetic patients.
    Hochberg I; Roguin A; Nikolsky E; Chanderashekhar PV; Cohen S; Levy AP
    Atherosclerosis; 2002 Apr; 161(2):441-6. PubMed ID: 11888529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating C-type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathy.
    Buckley MG; Jenkins GH; Mitchell AG; Yacoub MH; Singer DR
    Clin Sci (Lond); 2000 Nov; 99(5):467-72. PubMed ID: 11052928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.